Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Regis Healthcare Ltd. ( (AU:REG) ) has provided an update.
Regis Healthcare Limited has notified the market that 125,816 performance rights, classified under ASX security code REGAA, have lapsed. The lapse occurred because the conditions attached to these conditional rights were not met or could no longer be satisfied, resulting in a reduction of potential future equity issuance and signalling a tightening in the company’s outstanding performance-based securities.
The cessation of these securities, effective 6 January 2026, slightly alters Regis Healthcare’s capital position by removing these unvested rights from its pool of potential shares. This change may modestly affect dilution expectations for existing shareholders and provides transparency around the status of performance-linked incentives within the company’s remuneration framework.
The most recent analyst rating on (AU:REG) stock is a Hold with a A$7.00 price target. To see the full list of analyst forecasts on Regis Healthcare Ltd. stock, see the AU:REG Stock Forecast page.
More about Regis Healthcare Ltd.
Regis Healthcare Limited operates in the healthcare sector and is listed on the ASX under the code REG. The company’s issued capital structure includes performance rights as part of its equity-based remuneration or incentive arrangements for participants.
Average Trading Volume: 699,942
Technical Sentiment Signal: Buy
Current Market Cap: A$1.97B
Learn more about REG stock on TipRanks’ Stock Analysis page.